Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Dana Farber discloses unique antiherpetic therapy

Oct. 4, 1996

AmBisome licensed to Sumitomo

Oct. 4, 1996

Antiherpesvirus agents from Eisai

Oct. 4, 1996

Orally active cyclic depsipeptides from Schering-Plough

Oct. 4, 1996

SS Pharm. & Yoshitomi developing triazole antifungal agent

Oct. 4, 1996

BPI-derived fungicidal peptides from Xoma

Oct. 4, 1996

Semisynthetic pneumocandin analogue for fungal infections

Oct. 4, 1996

PathoGenesis selects nitroimidazopyran as potential tuberculosis Rx

Oct. 4, 1996

IntraBiotics' protegrins as potential treatments for multi-drug-resistant infections & gastric ulcer

Oct. 4, 1996

Potential antitubercular agents from PathoGenesis

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
$Silhouette of head and brainwith fractal art$
ATAI-dyed Lilly tees up in psychedelics, finds $3.8B fit
BioWorld
Rumblings that psychedelic treatments would soon be ready for prime time gained credence aplenty, and shares of Ataibeckley Inc. (NASDAQ:ATAI) ended July 16 at...